Skip to NavigationSkip to content

News

In a landmark ruling, a Californian court has found that a brand name manufacturer of a drug could be held liable for medical complications that...
Roche has announced that it will buy Ignyta, a San Diego-based biotech that has a pipeline of oncology drugs, for $1.7 billion.
Only a few months ago, it was announced that Eisai had decided to opt into the development process of BAN2401. The signal sent off by this...
New research has indicated that the mutational burden can provide a strong indicator as to whether a cancer will respond to checkpoint inhibitor...
The FDA has granted approval to Perjeta in combination with Herceptin and a chemotherapy regimen for the adjuvant treatment of HER2-positive early...
The FDA reveals it has approved Pfizer's Bosulif for the treatment of newly-diagnosed Ph+ chronic myelogenous leukaemia.
MSD and Pfizer have announced that their sodium-glucose co-transporter 2 (SGLT2) inhibitor has received approval by the FDA, for use as a single...
AbbVie posted strong results from its Phase 3 trial into its treatment for rheumatoid arthritis, upadacitinib, but discussions of the drug will...
Johnson & Johnson has been fined by France’s competition authority, Autorité de la Concurrence, after it alleges the company had intentionally...
Genentech has followed in the footsteps of its parent company by signing a drug discovery agreement with DiCE Molecules. The pact will see the two...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches